Novel Aminocyclohexenyl-6,6-bicyclic Compounds as 5-HT2A Receptor Agonists for Treating Depression, Anxiety, Substance Abuse, and Headaches
0 citations
Abstract
Abstract Provided herein are novel aminocyclohexenyl-6,6-bicyclic compounds as 5-HT2A receptor agonists, pharmaceutical compositions, use of such compounds in treating depression, anxiety, substance abuse and headaches, and processes for preparing such compounds.
// Source
Authors: Ram W. Sabnis, Anika R. Sabnis
Institutions: Mayo Clinic